Ophthonix™ Receives 14th Patent

SAN DIEGO--(BUSINESS WIRE)--Ophthonix, Inc., an ophthalmic company marketing technology that enables patients to see with fully optimized vision, has received its 14th patent. This patent includes the diagnostic capabilities of the Z-View™ Aberrometer to profile the high order aberrations of a patient’s eye with a proprietary algorithm. The high order profile is used to manufacture the iZon™ High Resolution Lens, giving the patient high definition vision. The patent also covers the use of the high order profile to generate a simulation of the high definition vision quality provided by the iZon Lens, for use by the practitioner in explaining the iZon Lens benefits to the patient.

MORE ON THIS TOPIC